These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 4772981

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. A clinical study of the metabolic effect of a new oral hypoglycemic agent: glipizide.
    Iacono G, Ghionni A, Colucci M, Verde G, Caputo G.
    Int J Clin Pharmacol; 1974 Apr; 7(3):225-31. PubMed ID: 4850166
    [No Abstract] [Full Text] [Related]

  • 25. [Therapeutic trial of a new antidiabetic with vascular action: 1702 SE].
    Jaillard J, Warembourg H.
    Lille Med; 1972 Oct; 17(9):Suppl 6:1332-6. PubMed ID: 4657429
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. [Oral hypoglycemic therapy of diabetes mellitus].
    Montenero P.
    Minerva Med; 1976 Jan 21; 67(3):208-15. PubMed ID: 1250219
    [No Abstract] [Full Text] [Related]

  • 28. Hypoglycemia in patients with type 2 diabetes from India and Malaysia treated with sitagliptin or a sulfonylurea during Ramadan: a randomized, pragmatic study.
    Aravind SR, Ismail SB, Balamurugan R, Gupta JB, Wadhwa T, Loh SM, Suryawanshi S, Davies MJ, Girman CJ, Katzeff HL, Radican L, Engel SS, Wolthers T.
    Curr Med Res Opin; 2012 Aug 21; 28(8):1289-96. PubMed ID: 22738801
    [Abstract] [Full Text] [Related]

  • 29. [A new antidiabetic agent: glyclazide. A study of glycemic regulation].
    Bour H, Denard Y, Plauchu M, Rathery M, Simonin R, Thervet F, Warembourg H.
    Nouv Presse Med; 1974 Feb 02; 3(5):249-51. PubMed ID: 4819946
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Insulin and oral hypoglycaemic agents. II. Clinical and therapeutic aspects.
    Breidahl HD, Ennis GC, Martin FI, Stawell JR, Taft P.
    Drugs; 1972 Feb 02; 3(3):204-26. PubMed ID: 4561637
    [No Abstract] [Full Text] [Related]

  • 34. [Clinical trial of a new oral antidiabetic: glypizide].
    Paes E, Gomes FJ, Pinto RE, De Alburquerque MA, Farinha H.
    Rev Iber Endocrinol; 1974 Feb 02; 21(125):459-62, 466-6, 469-70 passim. PubMed ID: 4422452
    [No Abstract] [Full Text] [Related]

  • 35. [Clinical experience with the blood sugar reducing sulfonamide derivative glisoxepide].
    Petzoldt R, Riedesel G, Ramrath M, Grabs V, Haupt E, Schwedes U, Ewald W, Beyer J, Schöffling K.
    Arzneimittelforschung; 1974 Mar 02; 24(0):429-32. PubMed ID: 4603399
    [No Abstract] [Full Text] [Related]

  • 36. [Therapeutic value of a new oral antidiabetic agent: gliclazide].
    Bernasconi D, Mazzi C.
    Clin Ter; 1978 Mar 31; 84(6):627-35. PubMed ID: 648108
    [No Abstract] [Full Text] [Related]

  • 37. Sitagliptin + metformin: new combination. Do not use this combination. Sitagliptin provides a slight increase of glucose-lowering effects, but there is a disturbing potential for long-term adverse effects: infections, depression, and cancer.
    Prescrire Int; 2009 Jun 31; 18(101):115. PubMed ID: 19637427
    [No Abstract] [Full Text] [Related]

  • 38. Unaltered glucagon secretion after seven days of sulphonylurea administration in normal subjects.
    Marco J, Valverde I.
    Diabetologia; 1973 Sep 31; ():317-9. PubMed ID: 4204092
    [No Abstract] [Full Text] [Related]

  • 39. Pharmacokinetics and pharmacodynamics as well as metabolism following orally and intravenously administered C14-glipizide, a new antidiabetic.
    Schmidt HA, Schoog M, Schweer KH, Winkler E.
    Diabetologia; 1973 Sep 31; ():320-30. PubMed ID: 4772978
    [No Abstract] [Full Text] [Related]

  • 40. Pharmacokinetics of glipizide in man: influence of renal insufficiency.
    Balant L, Zahnd G, Gorgia A, Schwarz R, Fabre J.
    Diabetologia; 1973 Sep 31; ():331-8. PubMed ID: 4772979
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.